. PLAGL2 expression-induced lung epithelium damages at bronchiolar alveolar duct junction in emphysema: bNip3-and SP-C-associated cell death/injury activity.
promote apoptosis rather than proliferation in BALB/c 3T3 and neuroblastoma Neuro2a cells (17) . Experiments with mouse macrophage cell line RAW264.7, erythroleukemia (MEL), and BALB/c 3T3 cells further revealed that PLAGL2 can be induced by hypoxia or "hypoxia mimics," namely cobalt chloride (CoCl 2 ) or the iron chelator desferrioxamine (6) . Consequently, upregulated PLAGL2 may modulate hypoxia-inducible factor-1 (HIF-1) downstream gene activity and promote HIF-1-associated cell death (17) , leading to a potential pathway for PLAGL2-mediated cell death in response to hypoxia in vivo. In our previous study, we (8) showed that H441 (human lung adenocarcinoma) cells responded to CoCl 2 -induced hypoxia by accumulating PLAGL2 in the nuclei. As a transcription factor, its nuclear accumulation is likely accompanied by the regulation of its downstream genes. Depending on the genes with which PLAGL2 interacts, PLAGL2 may program cells to undergo transformation, apoptosis, or stress response.
The known PLAGL2 downstream genes include surfactant protein C (SP-C; Ref. 36) , IGF-II (11), p67 phox (a cytosolic component of NADPH oxidase; Ref. 2) , and bNip3 (a proapoptotic protein that dimerizes with Bcl-2; Ref. 17 ). In addition, a variety of proteins have been reported to form complexes with PLAGL2 including Ubc9 (9) , protein inhibitor of activated STAT (PIAS; Ref. 32) , and Pirh2 (a p53-inducible E3 ligase for ubiquitination of p53; Refs. 32, 38) . In our previous study, we (9) showed that PLAGL2 transactivation of the SP-C promoter could be enhanced by Ubc9 in vitro. Here, using an inducible transgenic mouse model, we further demonstrate that PLAGL2 modulates SP-C expression in vivo.
Emphysema and chronic bronchitis are major pathological components of chronic obstructive pulmonary disease (COPD). Although considerable overlap between emphysema and chronic bronchitis exists, there are individuals who demonstrate predominantly one process over the other, producing the well-described "pink puffer" and "blue bloater" phenotypes. Pulmonary emphysema is defined as an abnormal permanent enlargement of the alveolar spaces distal to the terminal bronchioles accompanied by the destruction of their bronchiolar walls (1) . In contrast, chronic bronchitis is best characterized by inflammation of the conducting airways associated with hypertrophy of airway goblet cells and submucosal glands. Studies have shown correlation between morphologically characterized emphysema and lung function (23) . However, the strength of the relationship depends on the severity and homogeneity of the disease in the affected lung (3, 23) .
In this study, we demonstrated that long-term induction of PLAGL2 expression in lung epithelial cells resulted in the development of centrilobular emphysema. There was no clear evidence of inflammatory cell recruitment in the lungs or within the emphysematous lesions, suggesting that acute inflammation did not contribute to the phenotype. Instead, markers of cell injury/death were found in the emphysematous regions of the mouse lungs and at the bronchoalveolar duct junction (BADJ) where both PLAGL2-and SP-C-expressing cells were detected. PLAGL2 expression was also found to be increased in the lungs of COPD patients and correlated with disease severity. Together, these data strongly indicate that increased PLAGL2 expression in airway epithelial cells results in the dysregulation of cell homeostasis in the peripheral lung by promoting cell death particularly at the BADJ, leading to the development of emphysema.
MATERIALS AND METHODS

Generation of PLAGL2 transgenic mice and animal husbandry.
A tetracycline-inducible transgene expression system was used to control PLAGL2 expression in the lungs of transgenic mice. (TetO) 7CMV transgene vector and SP-C-rtTA transgenic mice were kindly provided by Dr. Whitsett (Cincinnati Children's Hospital Medical Center, Cincinnati, OH) and were reported previously (5) . A human PLAGL2 full-length cDNA fragment with an intron [extracted from the 2nd intron (the first 244 nt of the 5Ј end and the last 263 nt of the 3Ј end) of the human PLAGL2 gene] was subcloned with fixed orientation into the NotI site of (tetO) 7CMV transgene vector (Supplemental Fig.  S1 , available in the data supplement online at the AJP-Lung Cellular and Molecular Physiology web site) by exonuclease recession method (37) . The intron was positioned exactly at the original location within the gene with preserved original 5Ј and 3Ј exon/intron junction sequences.
The same strain of mouse (FVB/N) as the SP-C-rtTA transgenic mice was used to generate the (tetO) 7CMV-PLAGL2 transgenic mice. Four founders of PLAGL2 transgenic mice (P1ϳP4 with various copy numbers from estimated 4 to 180) were obtained and tested for gene expression. Each founder was bred with SP-C-rtTA ϩ/Ϫ mice to generate PLAGL2 ϩ/Ϫ /SP-C-rtTA ϩ/Ϫ double-transgenic (DT) mice for PLAGL2 expression. DT mice were identified by genotyping of tail DNA. PCR primers used to amplify the transgenes are listed in Table 1 . Hemizygous mice were selected for studies to avoid potential lethal mutations. Doxycycline (Dox) induction was performed by feeding animals (6 wk and older) with Dox H 2O at 1 mg/ml (35) in amber bottles. Dox H2O was replenished three times a week.
Mice were maintained in a barrier facility with a 12:12-h light-dark cycle, housed in sterilized cages, and given sterilized food and water ad libitum. All animals were handled under aseptic conditions. Animal studies were performed with protocols approved by the Institutional Animal Care and Use Committee of University of Texas Southwestern Medical Center.
Lung fixation and histology. Mouse lungs were removed en bloc from the thorax and inflated via tracheal cannula with 4% buffered paraformaldehyde at 25 cmH 2O pressure for 10 min at room temperature. They were then ligated and continuously fixed in 25 ml of 4% paraformaldehyde with gentle agitation overnight. Fixed lung tissues were then washed with phosphate-buffered saline, dehydrated, and embedded in paraffin for sectioning. The 5-m sections were cut and stained with hematoxylin and eosin (H&E) or probed with primary antibodies for immunohistochemical (IHC) staining.
RNA isolation and quantitative RT-PCR analysis. For total RNA isolation, the lungs were removed and snap-frozen in liquid N 2. Total RNA for RT-PCR and real-time PCR analysis was isolated from frozen lung tissue using the TRIzol reagent (Invitrogen, Carlsbad, CA) and following the manufacturer's protocols. Before converting RNA to cDNA, residual DNA was removed by using TURBO DNA-free Kit (Applied Biosystems/Ambion, Austin, TX). Purified RNA was subjected to cDNA synthesis using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) with oligo(dT) and random hexamers as primers. The synthesized cDNAs were within a size range of Ͻ1,000 bases.
All PCR amplicons were designed to be ϳ150 bp in length. Sizes of amplified samples were confirmed on a 1.5-2% agarose gel. For quantitative measurement of GAPDH, SP-C, SP-B, and thyroid transcription factor-1 (TTF-1) transcripts, real-time PCR analysis was employed by incorporating SYBR Green in the amplification reaction and cycling on an iCycler (Bio-Rad). The melting curve and correlation coefficiency of all samples analyzed were individually examined in the iCycler program to verify that the amplification truly indicated the expressed messages in those samples. Primers used for real-time PCR analyses were provided in the previous manuscript (36) . Two 10-folds of serial dilutions with duplicates were performed for every gene measurement in each sample, and the cycle threshold (C T) values collected from those diluted samples were taken into account to obtain the mean values for calculation.
TUNEL analysis. The TdT-mediated dUTP nick end labeling (TUNEL) method was used to examine apoptosis activity. After deparaffinization and rehydration, lung sections were treated with proteinase K (Roche, Indianapolis, IN) at a concentration of 5 g/ml for 20 min at room temperature. The tissues then were examined for cell death activity using the In Situ Cell Death Detection Kit, POD (Roche) with minor modification. One-tenth of TdT enzyme concentration suggested by manufacturer's protocol was mixed with the substrate solution to label the free DNA ends. The signal was then developed with 3,3Ј-diaminobenzidine (DAB). Positive signals were observed and scored under light microscopy. For negative control, a sequential section was processed side-by-side without incubation with TdT.
Morphometric analysis. To quantitate air space enlargement, measurement of mean linear intercept (MLI) was performed (30) . Fivemicrometer thick midcoronal lung sections were stained with H&E for morphological analysis. Images were acquired with Nikon Coolpix 990 color digital camera at a magnification of ϫ10. PLAGL2-induced emphysema is a centrilobular type, with normal alveolar sacs adjacent to enlarged air space lesions without clear boundary or separation. At least 3 images of nonoverlapped areas with enlarged or normal air spaces from each section were acquired for MLI measurements. The MLI within emphysematous lesions and normal tissues were calculated (represented as means Ϯ SE) and graphed. The differences of MLI between samples were statistically evaluated using t-test and one-factor ANOVA. P Ͻ 0.05 was accepted as significant difference.
Immunohistochemistry and antibodies. For SP-B, proSP-C (prosurfactant protein C; Chemicon/Millipore, Temecula, CA), and bNip3 (Novus Biologicals, Littleton, CO) detection, sections were directly treated with blocking and probing procedures after deparaffinization and rehydration. Before the blocking step, lung sections were subjected to antigen retrieval by heating in a microwave oven in 0.01 M citrate buffer (pH 6.0) before incubation with antibodies to TTF-1 (Upstate, Lake Placid, NY), Immunodetection was achieved using Vectastain ABC Elite Kit (Vector Laboratories, Burlingame, CA) and performed with a hematoxylin counterstain. Human COPD/emphysema (final clinical major diagnosis) patient lung sections were obtained from National Institutes of Health (NIH) Lung Tissue Research Consortium (LTRC) tissue bank. Lung patients from both sexes were grouped by predicted forced expiratory volume in 1 s (FEV 1) value as Ͻ50%, 50 -80%, and Ͼ80% (categorized originally by LTRC). Cell counts of positive PLAGL2 signals and the total area measurement of alveolar septa in each selected field were analyzed by the ImageJ program (NIH). To quantitate the expression of PLAGL2 in patient lungs, the staining signal in the cytoplasm of macrophage on the same slide section was used as the internal reference to define PLAGL2 expression level as high (Ն macrophage signal) or low (Ͻ macrophage signal). The level of PLAGL2 expression then was determined as the numbers of PLAGL2-positive cells (cell counts ϭ 2ϫ high expression cell counts ϩ low expression cell counts) per square millimeter of alveolar septa area measured.
Lung function analysis. Quasi-static transrespiratory pressure-volume (Pst,rs-V) data were obtained using the flexiVent rodent ventilator (SCIREQ, Montréal, Québec, Canada). Anesthesia was induced by the intraperitoneal injection of a ketamine cocktail (100 mg/kg ketamine, 10 mg/kg xylazine). Once mice were found to be adequately sedated (assessed by loss of paw prick reflex), the trachea was cannulated using a 20-gauge blunt tip catheter. The mice were then connected to the ventilator and ventilated with a respiratory rate of 300 beats/min, tidal volume of 8 ml/kg, positive end-expiratory pressure (PEEP) of 3 cmH 2O, and fraction of inspired oxygen (FIO 2 ) of 21%. After 10 min of ventilation, data collection was initiated.
Measurement of Pst,rs-V data. To obtain Pst,rs-V data, the volume history was standardized, and mice were kept at a 0 cmH 2O PEEP for 1 min while maintaining ventilation. Then, regular ventilation was suspended for 30 s to allow alveolar pressure to equilibrate to atmospheric pressure, and lung volume was raised to 30 ml/kg and decreased back to functional residual capacity (FRC) in a stepwise fashion. At each volume step, Pst,rs was measured. Immediately after data collection, regular ventilation was resumed. The nonlinear relationships of Pst,rs-V data were fit to a third order polynomial function, and lung compliance is expressed in terms of Pst,rs 20, 25, and 30 (i.e., the value of Pst,rs at 20, 25, or 30 ml/kg above FRC during inspiration; Ref. 26) . Statistical significance was determined by Student's t-test analysis with P values Յ0.05 being considered as significant.
RESULTS
Induced PLAGL2 transgene and SP-C expression in the lungs of DT mice. An inducible transgene expression system was used to control PLAGL2 expression in the mice. In this system, a SP-C promoter is used to direct the rtTA expression specifically to the lung, leading to an exclusive expression of the transgene in alveolar type II cells and bronchiolar epithelium (7, 31) . Real-time PCR and IHC analyses demonstrated that human PLAGL2 transgene was expressed only in the induced DT mice and has the same pattern as previously reported for the SP-C-rtTA transgene expression in mice (Ref. Given that PLAGL2 is a transactivator of the SP-C promoter, increased PLAGL2 expression was expected to result in a higher level of SP-C expression in the lungs. As shown in Fig. 1A , whereas RT-PCR analysis revealed no significant changes in TTF-1 and SP-B expression, the level of SP-C transcript increased significantly in the lungs of induced DT mice (P ϭ 0.037 and Ͻ0.001, respectively). In addition, IHC analysis shows that PLAGL2 promotes an ectopic expression of SP-C in the airway epithelium of the terminal bronchioles ( Fig. 1B, left column) . Neither PLAGL2 nor SP-C was detected in epithelial cells of the terminal bronchioles of the control mice (Fig. 1B, right column) . There was no difference in TTF-1 and SP-B expression patterns between these two groups of mice. Two different mouse founders were examined, and both had similar results. These results further support the regulatory role of PLAGL2 in SP-C promoter activity in vivo.
Induced PLAGL2 and SP-C expression in epithelial cells at the BADJ. SP-C-rtTA directs PLAGL2 transgene expression in type II cells, terminal bronchiolar epithelial cells (Ref. 21 ; Fig.  1B) , and epithelial cells at the BADJ (Fig. 2, A-C) . Interestingly, the frequency of PLAGL2-producing cells reduces immediately outside the BADJ toward the proximal region of the airways (Fig. 2) . Since the SP-C promoter is a PLAGL2 downstream target gene, we suspected that SP-C might be expressed in a similar pattern as PLAGL2 in the distal airways as well. The result was shown in Fig. 3 . SP-C proprotein also was expressed in epithelial cells at the BADJ in addition to type II cells in alveoli (Fig. 3, A-D) . The lungs of control mice exhibited no clustered PLAGL2-or SP-C-positive cells at the BADJ (Figs. 2D, 3E , and 3F).
Centrilobular emphysema developed in the lungs of PLAGL2 overexpression mice. In this study, the long-term effects of increased SP-C and PLAGL2 expressions on lung function and morphological changes were evaluated. All the mice used in this study were fed with Dox to induce PLAGL2 expression at the age of 6 -8 wk old and remained on the treatment until they were killed at the age of 5-8 mo old. Enlarged air spaces with heterogeneous spatial distribution occurred at the distal airways of induced DT mice (Fig. 4) . They represented typical phenotype of the centrilobular emphysema, which had normal lung parenchyma coexisting with the emphysematous lesions (Fig. 4, B and C) . The development of focal air space enlargement occurred mainly at the end of terminal bronchioles and alveolar ducts. The morphometric measurement of air spaces in the distal airways (alveolar ducts) and alveoli by MLI showed significantly enlarged air spaces in the lesions of the induced DT mouse lungs (Fig. 4D) . Statistical analysis of the MLI value differences between the induced and control mouse groups were significant (Fig. 4E) . Depending on the severity of airway destruction, almost all of the secondary alveolar septa were lost in the lesions with more advanced disease (Fig. 4C) . Defective alveolar walls and free parenchymal fragments (24) also were frequently observed within the lesions, indicating the ongoing destruction of alveolar walls (Fig. 5, A and B) . Both mouse founders exhibited similar phenotypes on induction, suggesting a pathological relevance between PLAGL2 expression and distal airway destruction. The degradation of distal airway walls was not seen in the control group (Fig. 5, C and D) . In the most severe case, an induced DT mouse exhibited total destruction of an entire lobe with only a large bullae remaining (Supplemental Fig. S2) . However, the other lung lobes appeared normal with intact structure except for enlarged air spaces (Supplemental Fig. S2 , C and E, and Fig. 4B ), indicating the natural heterogeneity of this pathological process.
Prevailing air space enlargement in female mice expressing PLAGL2. Of the DT (ϩDox) animals examined, female mice had a higher tendency to develop emphysema (ϳ90%; Table 2 ), whereas the control groups of both female and male mice had a similar background level (20%) of mild air space enlargement. The average ages of mice in these four groups (induced and control mice of both sexes) were all similar. The F test of two-sample variances (1-tail) showed that there were no differences in sample age variances between any two mouse groups. In addition, ANOVA showed that there were no mean value differences in age between these four groups (P ϭ 0.66). The sample size of female mice with type 1 error ␣ Ͻ 0.05 has statistical power of 98%, indicating that the examined sample numbers were adequate to reach the conclusion. The MLI differences between the induced DT mice and the control mice were statistically significant according to the Student's t-test analysis. *P Ͻ 0.05. Original magnification, ϫ4. The MLI from groups of induced DT mice (n ϭ 9) and control mice (n ϭ 6) were measured, summed, and calculated as described above. In E, the box plot of the MLIs of both groups were graphed, and their medians (solid line) were shown. The mean value (dashed line) of each group also was displayed. Statistical analyses by Kruskal-Wallis 1-way ANOVA of ranks and Mann-Whitney rank sum test both show that the differences in the median values between the 2 groups are greater than would be expected by chance; there is a statistically significant difference (P ϭ 0.003 and 0.004, respectively).
Increased cell injury and death activities in epithelial cells of the emphysematous lungs.
Given the absence of inflammatory cells, we investigated whether the disruption of cell homeostasis could be a cause of emphysema. TUNEL assay was first employed to test the possibility. In Fig. 6 , the result of the TUNEL assay indicated that cell death activity was increased in peripheral airway epithelial cells adjacent to the emphysematous lesions (Fig. 6, A and C) . DNA strands breakage, an indication of cell death, occurred frequently in the nuclei of lung parenchymal cells in the induced DT mice but rarely existed in the control mice or in the area of normal parenchymal structure (Fig. 6, B and D) . In addition, caspase-3-positive epithelial cells were detected at the BADJ in the induced DT mice, indicating increased apoptotic activity in this region (Fig. 6E ) compared with that in control mice (Fig. 6F) . The pattern of apoptotic epithelial cells at the BADJ overlapped with those cells of high PLAGL2 and SP-C immunoreactivity (Figs. 2 and 3) , suggesting that PLAGL2 and SP-C were pathogenic in mediating cell death activity. To test this possibility, expression of bNip3, a preapoptotic molecule and a downstream target gene of PLAGL2, was examined by IHC. As the result showed in Fig. 7 , A and B, bNip3 signal was increased in epithelial cells at the BADJ as well as in type II cells adjacent to the BADJ in induced DT mice, whereas its expression was low in the control mice (DT, ϪDox; Fig. 7, C  and D) . In addition, we also suspected that aberrant SP-C expression in airway bronchiolar cells could result in the accumulation and aggregation of misfolded SP-C proprotein within cells, leading to endoplasmic reticulum (ER) stressassociated cell injury and death (4). Therefore, ER stress markers ATF4 and ATF6 were used to investigate this possibility. These results demonstrate the upregulation of both ER stress markers in epithelial cells at the BADJ, indicating the presence of ongoing cell injury or damage (Fig. 7, E and F) . In contrast, only a few type II cells were detected with ATF6 immunoreactivity and rarely with ATF4 immunoreactivity (Fig. 7, E and F) . Similar to the study with bNip3, control animals did not exhibit a significant presence of these marker signals (data not shown).
Increased PLAGL2 expression in the lung parenchyma of COPD patients. Although induced PLAGL2 expression in lung epithelial cells could result in airway wall degradation in mice, it was not known whether PLAGL2 had any pathophysiological relevance to COPD in humans. Given that PLAGL2 responds to stress and increases its activity in lung cells under CoCl 2 -induced hypoxia condition (17, 36) , the increase of PLAGL2 expression in the emphysematous lungs is anticipated. Lung sections from COPD patients (LTRC ; Table 3) were examined for PLAGL2 expression. All the patients were noted to have a smoking history. IHC staining indicated that PLAGL2 expression level was high in airway epithelial cells of COPD patients with FEV 1 Ͻ50% compared with those with a FEV 1 Ͼ80% (Fig. 8) . Furthermore, quantitation of PLAGL2-positive airway epithelial cells in COPD patients categorized by disease severity (according to percent predicted FEV 1 value) demonstrated a positive correlation with PLAGL2 expression and disease severity. The differences in expression between each group were statistically analyzed, and the results are shown in Fig. 8C . PLAGL2 expression in the lungs of patients (FEV 1 50 -80%) with final major pathological report of COPD/emphysema (group A) has higher level than that of interstitial lung disease (ILD) or other lung diseases (group B) or of the control (FEV 1 Ͼ80%, including both diseases). The differences are statistically significant according to both MannWhitney rank sum test and Student's t-test studies. This result establishes a pathological linkage between PLAGL2 expression and emphysema manifestation in the lungs of COPD patients. In addition, the clinical data summarized in Table 3 show a sex preference with women representing the majority of patients with severe obstructive airway disease at their younger age (FEV 1 Ͻ50%). PLAGL2 overexpression results in increased respiratory system compliance in female mice. Pst,rs-V analysis of DT (ϩDox) mice show PLAGL2 induction results in a shift in the inspiratory pressure-volume curve to the left (Fig. 9) , indicating a significant increase in respiratory system compliance compared with control mice. These data indicate that PLAGL2 expression is associated with significant functional as well as structural changes in the respiratory system.
DISCUSSION
We (9, 36) have previously demonstrated that PLAGL2 is a transactivator of the SP-C promoter in vitro. In this study, using an inducible transgenic mouse system, we show that PLAGL2 specifically regulates SP-C promoter activity in vivo. Dox induction of PLAGL2 expression increases the level of SP-C expression in the lungs, whereas both TTF-1 and SP-B remained the same (Fig.  1A) , indicating that PLAGL2 expression did not increase the population of type II epithelial cells nor did it enhance the production of surfactant proteins in general. Normally, it is uncommon to find SP-C expression in epithelial cells at terminal bronchioles or the BADJ. Only rare bronchoalveolar stem cells at the BADJ coexpress both SP-C and Clara cell-specific protein Fig. 6 . Apoptosis activity was increased in the lungs of induced DT mice. Lung sections from the induced DT mouse were examined for the free ends of DNA fragments by TdT-mediated dUTP nick end labeling (TUNEL) assay. The areas with emphysematous (A and C) or normal tissue (B and D) structure were selected for examination. At higher magnification (C and D), there were clearly more TUNEL-positively stained cells in the area with enlarged air spaces (C) than that with normal parenchymal structure (D). The rectangles in A and C illustrate the selected region to be examined under higher magnifications. Arrowheads depict TUNEL-positively stained cells. Cell nuclei were counterstained with hematoxylin. In E and F, caspase-3 activity was increased in epithelial cells at the BADJ and nearby alveoli. Lung sections from the induced DT mice (E) or PLAGL2 single transgenic control mice (F, agematched littermate, ϪDox) were probed with an antibody to the active form of caspase-3. Epithelial cells stained positively for caspase-3 (brown color) along the bronchiolar wall were marked by the red line and in alveoli by arrows. *Enlarged air space. Original magnification, ϫ20. (14) . Thus the presence of clustered PLAGL2-and SP-C-positive cells at the BADJ suggests that ectopic PLAGL2 activates SP-C expression in cells at this region. Of note, it is not clear why PLAGL2 is differentially expressed in epithelial cells between proximal conductive airways and distal airways. One possible explanation is that PLAGL2 is a developmentally regulated protein, and its expression may be downregulated through the differentiation process. Further investigation is necessary to reveal the underlying mechanism.
Air space enlargement was the primary structural defect seen in DT (ϩDox) mice and is consistent with centrilobular emphysema seen in advanced COPD (Fig. 4, B and C) . This abnormality did not occur to the same extent in controls, which were either uninduced, age-matched littermates of the DT mice (Fig. 4A) or the single transgenic mice [(tetO) 7 CMV-PLAGL2 ϩ/Ϫ and SP-C-rtTA ϩ/Ϫ ] with or without Dox treatment (data not shown). Different mouse founders exhibited the same phenotype with the induced PLAGL2 expression, indicating that the transgene integration sites did not contribute to the observed phenotype (Figs. 4 and 5, Table 2 ). None of the parameters including gene copy numbers, Dox exposure (see discussion below), promoter squelching problems, or agerelated airway enlargement in senile lungs (33) contributed to the observed abnormality. Thus we conclude that there is a pathological correlation between PLAGL2 expression and the onset of this type of emphysema.
Although rtTA toxicity may be associated with emphysema in mice (27) , the SP-C promoter-driven mice do not have this phenotype (21) especially in the FVB/N background (18) , which is the strain used in this study for both transgenic mice. In addition, the pattern of heterogeneous distribution of the enlarged air space observed in the induced DT mice (centrilobular emphysema) is not consistent with the type of emphysema associated with rtTA (18, 27) ; instead, it is similar to that which occurs in the elastase-treated mice (20) . Given that Dox has pan-anti-MMP inhibitor activity (35) , long-term presence of Dox may interfere and attenuate the emphysema development in vivo. Thus PLAGL2 expression plays a pathogenic role in the disease development in this animal model. The emphysematous lungs were identified by the increase in MLI along with the presence of structural destructions such as defects in alveolar wall or septa, destroyed airway wall segments in conductive airways, or reduced secondary alveolar septa (Ref. 24 ; Fig. 5, A and B) . These signs are consistent with ongoing airway destruction and are easily differentiated from artifacts caused by overinflation of the lung during fixation. Furthermore, the attenuated alveogenesis mechanism in this PLAGL2-related emphysema model is also eliminated.
Many environmental stimuli such as smoke, oxidants, or stressful conditions are known to cause emphysematous lung disease in various animal models. During this study, the mice were not exposed to any of these agents. Given that PLAGL2 can respond to environmental stress and translocate into nucleus under a CoCl 2 -induced hypoxia condition (6, 8) , induced PLAGL2 expression may represent a critical cellular response to outside stresses. In addition, Ubc9, a SUMO-conjugating enzyme that interacts with PLAGL2 via protein-to-protein interactions, may act as a chaperon to translocate PLAGL2 into the nucleus and activate its downstream gene activity in vivo in responding to the environmental stress (8, 9) . The increase of SUMOylation activity is commonly observed in cells under various stress conditions, and thus this further supports a physiological role of Ubc9 in mediating PLAGL2-programmed cellular response. Overall, PLAGL2 expression is elevated in airway epithelial cells in patients with severe COPD (the majority of patients within the Ͻ50% group who have a FEV 1 value Ͻ20%; Fig. 8B ) and correlated with emphysema ( Fig. 8C) , further supporting the hypothesis that PLAGL2 expression is relevant to COPD pathogenesis. The values in parentheses represent the mean age of both men and women together. *Differences in age between patients of the predicted forced expiratory volume in 1 s (FEV1) Ͻ50% and of the subgroups of 50 -80% (groups A and B) are statistically different (P Ͻ 0.05, Student's t-test). All patients had smoking history, and 1 patient in the FEV1 Ͼ80% group was a current smoker at the time of tissue sampling. A, emphysema; B, interstitial lung disease (ILD) and other lung diseases; COPD, chronic obstructive pulmonary disease. Fig. 8 . Expression of PLAGL2 was elevated in epithelial cells of the chronic obstructive pulmonary disease (COPD) lungs. IHC staining of lung sections from the COPD patients with forced expiratory volume in 1 s (FEV1) Ͼ80% (A) or Ͻ50% (B) were examined for PLAGL2 expression. The sections were counterstained with hematoxylin after the IHC protocol. Open triangles point to alveolar macrophages in the air spaces, and the red strikes depict PLAGL2-positively stained epithelial cells in alveolar septa. Original magnification, ϫ20. C: box plot of PLAGL2-positive cell counts in the lung sections from COPD patients with various severities (grouped by FEV1 Ͻ50%, 50 -80%, and Ͼ80%, respectively). Five randomly selected, nonoverlapping lung peripheral parenchyma fields from each sample were picked for cell count analysis. The intensity of PLAGL2 expression was expressed in cell counts per square millimeter of alveolar septa area. The median value from each group is shown in solid lines, and mean value in dashed lines with the numbers. The differences between compared groups with statistical analyses of P value (Mann-Whitney rank sum test and Student's t-test) Ͻ0.05 were accepted as significant. The data from patients with emphysema diagnosed in the final pathological report were grouped as A and others as B. ILD, interstitial lung disease.
Although imbalanced protease/antiprotease activities (25) , alteration of oxidant/antioxidant balance (22) , and autoimmunity (15, 28) are causative mechanisms for alveolar wall destruction during the lung injury, disruption of lung homeostatic maintenance and repair system by altering apoptosis, cell proliferation, or cell senescence activities plays another role in the pathogenesis of the disease (29) . In our system, PLAGL2-induced expression results in excessive cell death, contributing to the loss of epithelial cells in distal airways. This is indicated by increased TUNEL-positive lung parenchymal cells in or around the emphysematous lesions (Fig. 6, A and C) and cell apoptotic activity in epithelial cells at the BADJ (Fig. 6E) . Mechanistically speaking, weakening of the airway wall in the terminal bronchioles and BADJ could lead to structural failure, becoming the fulcrum for the development of centrilobular emphysema within these animals. Although the influx of inflammatory cells was not commonly found within the emphysematous lesions in this model, macrophages were present in the lungs of induced as well as uninduced mice (Fig. 2) . The need of recruiting additional scavengers to clear the debris and dead cells in the diseased lungs is not absolute under such a chronic, noninflammatory processed condition.
The role of PLAGL2-induced airway wall destruction in COPD may be multifactorial. 1) PLAGL2 mediated upregulation of bNip3/Bcl-2 apoptotic pathway. BNip3 is a proapoptotic protein that dimerizes with Bcl-2 and promotes apoptosis (17) . Its expression is increased concurrently with PLAGL2 in epithelial cells at the BADJ and nearby type II cells of the induced DT mice (Fig. 7, A and B) , and these cells exhibited high caspase-3 activity (Fig. 6E). 2) PLAGL2 provoked cell injury associated with aberrant SP-C expression (19) . The SP-C proprotein is processed and packaged for secretion in type II cells in parallel with SP-B (10, 34) . In the PLAGL2-overexpressed animals, SP-C proprotein, but not SP-B, is expressed in terminal bronchiolar epithelial cells that could result in unprocessed, misfolded SP-C proprotein aggregation in ER, leading to ER stress and cellular injury (4). The presence of ER stress markers ATF4 and ATF6 in epithelial cells at the BADJ strongly supports this mechanistic possibility (Fig. 7, E and F) . These stress-injured cells, subsequently, could be exacerbated by PLAGL2-induced bNip3/Bcl-2 apoptosis, leading to the dysregulation of cell homeostasis in the region and the destruction of distal airway walls in the lung. This is the first study to illustrate that PLAGL2 can mediate airway epithelial cell injury and apoptosis in vivo, resulting in both structural and functional defects in the lungs consistent with centrilobular emphysema. Because PLAGL2 expression increases in patients with COPD/emphysema and associates with disease severity, our data suggest a pathophysiological role for PLAGL2 in disease progression. Future experiments employing a knockout technology will be needed to further determine whether blocking PLAGL2 expression is sufficient to suppress or to attenuate the disease progression in vivo. The specific correlation between PLAGL2 expression and emphysema, but not other lung diseases (Fig. 8C) , indicates PLAGL2 may be a better biomarker for the prediction of emphysematous lung disease than percent predicted FEV 1 alone in patients with advanced COPD. Given that PLAGL2 expression level remains high in lung epithelial cells of the COPD patients after they stopped smoking, cigarette smoke exposure is not necessary for continuous expression of PLAGL2 in vivo. Taken together, our data suggest that prolonged expression of PLAGL2 in the lungs can damage lung parenchymal structure, in particular at the BADJ, and cause airway space enlargement.
Although it is currently unclear why female mice demonstrated a more robust phenotype, it may be due to the differential effect of estrogen signaling on the PLAGL2-mediated pathways between male and female animals. Another possible interpretation is that MMP-26 (16) , an estrogen-dependent matrix metalloproteinase and a potent proteinase of ␣ 1 -antitrypsin, may have higher activity in female mice, thus leading to elevated elastase activity and exacerbated PLAGL2-induced airway destruction in vivo. Interestingly, our analysis of human samples from LTRC revealed a similar result. Female patients represented at least a 3-to-1 majority (Ն75%) compared with male patients in the group with severe COPD (FEV 1 Ͻ50%; Table 3 ). The mean age of patients in this group was younger than that in the group with moderate COPD (50 -80%). The reason for younger patient age could be due to the following: 1) patients were exposed to cigarette smoke at an earlier age; 2) patients have genetic background more accessible to the disease; or 3) females are more vulnerable than males to the disease. Future statistical study with a larger sample size is needed to determine and confirm the sex influence on the risk of developing emphysematous lung disease in humans, and the underlying mechanisms remain to be fully elucidated.
